OrganiGram Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . OrganiGram Holdings
OGI Stock  USD 1.07  0.04  3.88%   
OrganiGram Holdings financial statements provide useful quarterly and yearly information to potential OrganiGram Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on OrganiGram Holdings financial statements helps investors assess OrganiGram Holdings' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting OrganiGram Holdings' valuation are summarized below:
Gross Profit
54.6 M
Profit Margin
(0.32)
Market Capitalization
137.8 M
Enterprise Value Revenue
0.962
Revenue
166.1 M
We have found one hundred twenty available trending fundamental ratios for OrganiGram Holdings, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of OrganiGram Holdings recent fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 269.8 M. Enterprise Value is estimated to decrease to about 262.9 M

OrganiGram Holdings Total Revenue

193.01 Million

Check OrganiGram Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OrganiGram Holdings' main balance sheet or income statement drivers, such as Interest Expense of 303.5 K, Selling General Administrative of 58.3 M or Other Operating Expenses of 236.1 M, as well as many indicators such as Price To Sales Ratio of 2.86, Dividend Yield of 0.0 or PTB Ratio of 0.82. OrganiGram financial statements analysis is a perfect complement when working with OrganiGram Holdings Valuation or Volatility modules.
  
Check out the analysis of OrganiGram Holdings Correlation against competitors.
For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.

OrganiGram Holdings Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets266.4 M469 M242.7 M
Slightly volatile
Total Current Liabilities64.4 M61.3 M23.6 M
Slightly volatile
Total Stockholder Equity212.6 M351.9 M192.3 M
Slightly volatile
Cash128.9 M122.8 M41.1 M
Slightly volatile
Non Current Assets Total145.5 M167.5 M119.4 M
Slightly volatile
Non Currrent Assets Other645.7 K679.6 K8.5 M
Pretty Stable
Cash And Short Term Investments63.1 M123.7 M58.3 M
Slightly volatile
Net Receivables44.9 M42.7 M16.4 M
Slightly volatile
Common Stock Shares Outstanding130.9 M124.6 M47.3 M
Slightly volatile
Liabilities And Stockholders Equity266.4 M469 M242.7 M
Slightly volatile
Other Stockholder Equity40.1 M38.2 M17.1 M
Slightly volatile
Total Liabilities123 M117.2 M54.7 M
Slightly volatile
Total Current Assets316.6 M301.6 M136.2 M
Slightly volatile
Property Plant And Equipment Net132.4 M110.7 M98.6 M
Slightly volatile
Accounts Payable56.9 M54.2 M19.8 M
Slightly volatile
Common Stock Total Equity508 M483.8 M233.8 M
Slightly volatile
Non Current Liabilities Total35.1 M55.8 M29.6 M
Slightly volatile
Common Stock1 B980.8 M388 M
Slightly volatile
Short and Long Term Debt Total3.8 M4 M19.5 M
Very volatile
Net Tangible Assets258.4 M300.1 M184.8 M
Slightly volatile
Long Term Debt21.4 K22.5 K17.6 M
Very volatile
Long Term Debt Total35.1 M53 M31 M
Slightly volatile
Inventory59.9 M94.9 M44.3 M
Slightly volatile
Short and Long Term Debt65.5 K69 K1.1 M
Very volatile
Short Term Debt2.2 M1.2 M1.5 M
Pretty Stable
Property Plant Equipment150 M113.9 M101.8 M
Slightly volatile
Net Invested Capital386 M352 M251.2 M
Slightly volatile
Net Working Capital178.1 M240.2 M124.3 M
Slightly volatile
Capital Stock595.8 M980.8 M424 M
Slightly volatile

OrganiGram Holdings Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative58.3 M55.5 M22.5 M
Slightly volatile
Other Operating Expenses236.1 M224.8 M105.4 M
Slightly volatile
Total Operating Expenses49.5 M95.7 M45.6 M
Slightly volatile
Depreciation And Amortization12.4 M13.9 M9.4 M
Slightly volatile
Selling And Marketing Expenses24 M22.8 M10.1 M
Slightly volatile
Total Revenue193 M183.8 M69 M
Slightly volatile
Cost Of Revenue67.3 M129.2 M54.4 M
Slightly volatile
Interest Income12.4 M11.8 M6.1 M
Slightly volatile
Reconciled Depreciation15.7 M13.9 M9.4 M
Slightly volatile

OrganiGram Holdings Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow25.8 M38.9 M23.1 M
Slightly volatile
Capital Expenditures5.8 M6.1 M24.8 M
Pretty Stable
End Period Cash Flow128.9 M122.8 M41.1 M
Slightly volatile
Stock Based Compensation4.9 M8.3 M4.2 M
Slightly volatile
Depreciation12.5 M13.9 M9.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.863.00851.2549
Slightly volatile
PTB Ratio0.820.86344.2364
Slightly volatile
Days Sales Outstanding11311073.7738
Slightly volatile
Book Value Per Share6.916.57862.9649
Slightly volatile
Average Payables4 M3.8 M2.9 M
Slightly volatile
Stock Based Compensation To Revenue0.03340.03520.0359
Pretty Stable
Capex To Depreciation1.861.95841.0153
Slightly volatile
PB Ratio0.820.86344.2364
Slightly volatile
EV To Sales2.432.56161.0014
Slightly volatile
Inventory Turnover0.861.67311.4888
Slightly volatile
Days Of Inventory On Hand190218238
Slightly volatile
Payables Turnover1.912.79564.2473
Pretty Stable
Sales General And Administrative To Revenue0.280.29050.3211
Slightly volatile
Average Inventory33.2 M31.6 M24.2 M
Slightly volatile
Research And Ddevelopement To Revenue0.03420.04090.0754
Slightly volatile
Capex To Revenue0.320.33450.1895
Pretty Stable
Cash Per Share1.061.28080.483
Slightly volatile
Days Payables Outstanding137131101
Pretty Stable
Intangibles To Total Assets0.10.09740.0425
Slightly volatile
Current Ratio5.74.00876.1586
Very volatile
Tangible Book Value Per Share3.025.85042.5975
Slightly volatile
Receivables Turnover5.163.32435.2144
Slightly volatile
Shareholders Equity Per Share6.916.57862.9649
Slightly volatile
Debt To Equity0.00630.00660.0158
Slightly volatile
Capex Per Share0.640.63160.2716
Slightly volatile
Graham Net Net0.641.25470.6664
Slightly volatile
Average Receivables1.2 M1.2 M1.1 M
Slightly volatile
Revenue Per Share0.971.8881.7747
Slightly volatile
Debt To Assets0.00550.00580.0142
Slightly volatile
Graham Number4.668.726.4205
Slightly volatile
Operating Cycle264328293
Slightly volatile
Price Book Value Ratio0.820.86344.2364
Slightly volatile
Days Of Payables Outstanding137131101
Pretty Stable
Ebt Per Ebit0.350.37081.5606
Slightly volatile
Company Equity Multiplier1.81.13591.4574
Pretty Stable
Long Term Debt To Capitalization3.0E-43.0E-43.0E-4
Slightly volatile
Total Debt To Capitalization0.00620.00660.0156
Slightly volatile
Debt Equity Ratio0.00630.00660.0158
Slightly volatile
Net Income Per E B T1.161.141.0061
Slightly volatile
Cash Ratio1.181.23932.3476
Slightly volatile
Cash Conversion Cycle303197203
Slightly volatile
Days Of Inventory Outstanding190218238
Slightly volatile
Days Of Sales Outstanding11311073.7738
Slightly volatile
Price To Book Ratio0.820.86344.2364
Slightly volatile
Fixed Asset Turnover0.450.56121.391
Slightly volatile
Debt Ratio0.00550.00580.0142
Slightly volatile
Price Sales Ratio2.863.00851.2549
Slightly volatile
Asset Turnover0.160.25270.4565
Slightly volatile
Gross Profit Margin0.210.21650.2362
Very volatile
Price Fair Value0.820.86344.2364
Slightly volatile

OrganiGram Holdings Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap269.8 M438.7 M190.7 M
Slightly volatile
Enterprise Value262.9 M373.5 M122.2 M
Slightly volatile

OrganiGram Fundamental Market Drivers

Forward Price Earnings28.9855
Cash And Short Term Investments107.6 M

OrganiGram Upcoming Events

1st of February 2024
Upcoming Quarterly Report
View
9th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
17th of December 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

About OrganiGram Holdings Financial Statements

Investors use fundamental indicators, such as OrganiGram Holdings' revenue or net income, to determine how well the company is positioned to perform in the future. Although OrganiGram Holdings' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue108.1 K113.5 K
Total Revenue183.8 M193 M
Cost Of Revenue129.2 M67.3 M
Stock Based Compensation To Revenue 0.04  0.03 
Sales General And Administrative To Revenue 0.29  0.28 
Research And Ddevelopement To Revenue 0.04  0.03 
Capex To Revenue 0.33  0.32 
Revenue Per Share 1.89  0.97 
Ebit Per Revenue(0.27)(0.28)

Currently Active Assets on Macroaxis

VVisa Class A
CRMSalesforce
CRMSalesforce
MSFTMicrosoft
VVisa Class A
When determining whether OrganiGram Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OrganiGram Holdings' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Organigram Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Organigram Holdings Stock:
How To Invest In OrganiGram
Details
Is OrganiGram Stock a good investment?
Details
What is OrganiGram Holdings' Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of OrganiGram Holdings Correlation against competitors.
For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.34)
Revenue Per Share
1.606
Quarterly Revenue Growth
0.172
Return On Assets
(0.06)
Return On Equity
(0.55)
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY